First Manhattan Portfolio holdings
AUM
$35.4B
This Quarter Return
+4.01%
1 Year Return
+24.51%
3 Year Return
+86.41%
5 Year Return
+172.47%
10 Year Return
+337.52%
AUM
$26.1B
AUM Growth
+$26.1B
(-4.4%)
Cap. Flow
-$1.93B
Cap. Flow
% of AUM
-7.41%
Top 10 Holdings %
Top 10 Hldgs %
59.52%
Holding
1,775
New
87
Increased
235
Reduced
606
Closed
249
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$79.2M |
| 2 |
KKR & Co
KKR
|
$71M |
| 3 |
Visa
V
|
$58.8M |
| 4 |
Linde
LIN
|
$54.4M |
| 5 |
Brookfield
BN
|
$43.5M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$1.82B |
| 2 |
Amazon
AMZN
|
$65.7M |
| 3 |
Apple
AAPL
|
$62.2M |
| 4 |
Brookfield Asset Management
BAM
|
$61.7M |
| 5 |
Keysight
KEYS
|
$41.1M |
Sector Composition
| 1 | Financials | 44.87% |
| 2 | Technology | 16.36% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 8.04% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
United Therapeutics
UTHR
$17.9B
| $31.2M | 0.12% |
139,400
-44,000
| -24% | -$9.85M |
|
77
Immunocore
IMCR
$1.73B
| $30.3M | 0.12% |
613,749
| – | – |
|
78
Boston Scientific
BSX
$159B
| $30M | 0.12% |
600,217
-468
| -0.1% | -$23.4K |
|
79
Eli Lilly
LLY
$660B
| $29M | 0.11% |
84,320
-3,750
| -4% | -$1.29M |
|
80
Bilibili
BILI
$9.1B
| $28.9M | 0.11% |
1,231,794
-2,032
| -0.2% | -$47.8K |
|
81
Snap-on
SNA
$16.8B
| $28.9M | 0.11% |
117,198
-1,918
| -2% | -$474K |
|
82
American Water Works
AWK
$27.4B
| $28.3M | 0.11% |
193,301
-2,367
| -1% | -$347K |
|
83
Graco
GGG
$13.9B
| $26.6M | 0.1% |
395,807
-153,966
| -28% | -$10.3M |
|
84
Arrowhead Research
ARWR
$3.72B
| $26.1M | 0.1% |
1,025,654
| – | – |
|
85
Hilton Worldwide
HLT
$65.1B
| $25.6M | 0.1% |
181,641
-1,803
| -1% | -$254K |
|
86
PepsiCo
PEP
$203B
| $25.5M | 0.1% |
139,929
-3,193
| -2% | -$582K |
|
87
Diageo
DEO
$61.2B
| $25.4M | 0.1% |
151,751
+26,186
| +21% | +$4.38M |
|
88
Charles Schwab
SCHW
$175B
| $25M | 0.1% |
478,095
-143,340
| -23% | -$7.51M |
|
89
Merck
MRK
$213B
| $24.4M | 0.09% |
229,063
-8,321
| -4% | -$885K |
|
90
Exxon Mobil
XOM
$477B
| $23.9M | 0.09% |
217,526
-4,050
| -2% | -$444K |
|
91
Nutrien
NTR
$27.7B
| $23.3M | 0.09% |
317,900
-3,321
| -1% | -$244K |
|
92
Vanguard High Dividend Yield ETF
VYM
$63.5B
| $23M | 0.09% |
218,252
-125
| -0.1% | -$13.2K |
|
93
Nice
NICE
$8.43B
| $22.3M | 0.09% |
111,229
+2,097
| +2% | +$420K |
|
94
Abbott
ABT
$227B
| $22.1M | 0.08% |
217,944
+4,413
| +2% | +$447K |
|
95
Brookfield Renewable
BEP
$7.09B
| $21.2M | 0.08% |
672,308
-82,755
| -11% | -$2.61M |
|
96
IBM
IBM
$225B
| $20.7M | 0.08% |
158,281
-34,964
| -18% | -$4.58M |
|
97
Wells Fargo
WFC
$260B
| $19.4M | 0.07% |
518,565
-46,668
| -8% | -$1.74M |
|
98
Commercial Metals
CMC
$6.31B
| $19.2M | 0.07% |
393,584
-70,420
| -15% | -$3.44M |
|
99
Boeing
BA
$176B
| $18.8M | 0.07% |
88,344
-20,054
| -19% | -$4.26M |
|
100
Idexx Laboratories
IDXX
$50.6B
| $18.4M | 0.07% |
36,885
-9
| -0% | -$4.5K |
|